Patterns of progression, treatment of progressive disease and post-progression survival in the New EPOC study.
Valle, Juan W
Garden, O J
AffiliationUniversity Surgery and Cancer Sciences Division, University of Southampton, Southampton General Hospital, Southampton SO16 6YD
MetadataShow full item record
AbstractThe addition of cetuximab (CTX) to perioperative chemotherapy (CT) for operable colorectal liver metastases resulted in a shorter progression-free survival. Details of disease progression are described to further inform the primary study outcome.
CitationPatterns of progression, treatment of progressive disease and post-progression survival in the New EPOC study. 2016, 115 (4):420-4 Br. J. Cancer
JournalBritish Journal of Cancer